Clinicopathological characteristics and prognosis of multilocular cystic renal neoplasm of low malignant potential

  • Le YU ,
  • Shaohui DENG ,
  • Fan ZHANG ,
  • Ye YAN ,
  • Jianfei YE ,
  • Shudong ZHANG
Expand
  • Department of Urology, Peking University Third Hospital, Beijing 100191, China

Received date: 2024-03-15

  Online published: 2024-07-23

Supported by

the National Natural Science Foundation of China(82273389)

Abstract

Objective: To analyze the clinicopathological characteristics and prognosis of patients with multilocular cystic renal neoplasm of low malignant potential and compare the clinicopathological characteristics of patients with multilocular cystic renal neoplasm of low malignant potential who underwent different surgical methods. Methods: Clinicopathological data and prognosis of patients admitted to Peking University Third Hospital from January 2010 to September 2023 were collected. Patients who underwent radical nephrectomy or nephron-sparing surgery and were pathologically diagnosed with multilocular cystic renal neoplasm of low malignant potential were identified. Based on the surgical methods, the patients were divided into radical nephrectomy group and nephron-sparing surgery group. The clinicopathological characteristics of the two groups were compared. Results: A total of 35 patients were enrolled in this study. The median age at diagnosis was 53.0 (39.0-62.0) years. Among the 35 patients, 23 were males (65.7%) and 12 were females (34.3%). Nine patients underwent radical nephrectomy (25.7%), while 26 patients underwent nephron-sparing surgery (74.3%). The clinical T-stage of 35 patients did not exceed T2a stage. The median operation time was 145.0 min, and the median estimated intraoperative blood loss was 20.0 mL. The median postoperative hospitalization days was 6.0 d. The postoperative pathological results did not indicate renal sinus invasion, sarcomatous change, adrenal invasion or lymph node invasion. Based on the surgical methods, the patients were divided into a radical nephrectomy group and a nephron-sparing surgery group. There was no significant difference in clinicopathological charac-teristics between the two groups. Except for one patient who was lost to the follow-up, all the other patients were followed up for 8-111 months, with a median follow-up time of 70.5 months. Only one patient died from non-cancer-specific reasons, other patients had no tumor metastasis or recurrence. Conclusion: Patients with multilocular cystic renal neoplasm of low malignant potential have a good prognosis. There is no significant difference in clinicopathological characteristics of patients between nephron-sparing surgery group and radical nephrectomy group for multilocular cystic renal neoplasm of low malignant potential.

Cite this article

Le YU , Shaohui DENG , Fan ZHANG , Ye YAN , Jianfei YE , Shudong ZHANG . Clinicopathological characteristics and prognosis of multilocular cystic renal neoplasm of low malignant potential[J]. Journal of Peking University(Health Sciences), 2024 , 56(4) : 661 -666 . DOI: 10.19723/j.issn.1671-167X.2024.04.019

References

1 Siegel RL , Miller KD , Fuchs HE , et al. Cancer statistics, 2022[J]. CA Cancer J Clin, 2022, 72 (1): 7- 33.
2 Moch H , Cubilla AL , Humphrey PA , et al. The 2016 WHO classification of tumours of the urinary system and male genital organs. Part A: Renal, penile, and testicular tumours[J]. Eur Urol, 2016, 70 (1): 93- 105.
3 Li T , Chen J , Jiang Y , et al. Multilocular cystic renal cell neoplasm of low malignant potential: A series of 76 cases[J]. Clin Genitourin Cancer, 2016, 14 (6): e553- e557.
4 Westerman ME , Cheville JC , Lohse CM , et al. Long-term outcomes of patients with low grade cystic renal epithelial neoplasms[J]. Urology, 2019, 133, 145- 150.
5 Suzigan S , López-Beltrán A , Montironi R , et al. Multilocular cystic renal cell carcinoma: A report of 45 cases of a kidney tumor of low malignant potential[J]. Am J Clin Pathol, 2006, 125 (2): 217- 222.
6 Kashan M , Ghanaat M , H?tker AM , et al. Cystic renal cell carcinoma: A report on outcomes of surgery and active surveillance in patients retrospectively identified on pretreatment imaging[J]. J Urol, 2018, 200 (2): 275- 282.
7 Silverman SG , Pedrosa I , Ellis JH , et al. Bosniak classification of cystic renal masses, version 2019: An update proposal and needs assessment[J]. Radiology, 2019, 292 (2): 475- 488.
8 Alrumayyan M , Raveendran L , Lawson KA , et al. Cystic renal masses: Old and new paradigms[J]. Urol Clin North Am, 2023, 50 (2): 227- 238.
9 Yang B , Sun L , Cao WF , et al. Clear cell renal cell carcinoma with cystic component similar to multilocular cystic renal neoplasm of low malignant potential: A rare pattern of cyst-dependent progression from multilocular cystic renal neoplasm of low malignant potential[J]. Diagn Pathol, 2023, 18 (1): 27.
10 Pini GM , Lucianò R , Colecchia M . Cystic clear cell renal cell carcinoma: A morphological and molecular reappraisal[J]. Can-cers (Basel), 2023, 15 (13): 3352.
11 Kim SH , Park WS , Chung J . SETD2, GIGYF2, FGFR3, BCR, KMT2C, and TSC2 as candidate genes for differentiating multi-locular cystic renal neoplasm of low malignant potential from clear cell renal cell carcinoma with cystic change[J]. Investig Clin Urol, 2019, 60 (3): 148- 155.
12 Raspollini MR , Castiglione F , Martignoni G , et al. Unlike in clear cell renal cell carcinoma, KRAS is not mutated in multilocular cystic clear cell renal cell neoplasm of low potential[J]. Virchows Arch, 2015, 467 (6): 687- 693.
13 Shan K , Fu A , Liu N , et al. Contrast-enhanced ultrasound (CEUS) vs contrast-enhanced computed tomography for multilocular cystic renal neoplasm of low malignant potential: A retrospective analysis for diagnostic performance study[J]. Medicine (Baltimore), 2020, 99 (46): e23110.
14 Bhatt JR , Jewett MA , Richard PO , et al. Multilocular cystic renal cell carcinoma: Pathological T staging makes no difference to favorable outcomes and should be reclassified[J]. J Urol, 2016, 196 (5): 1350- 1355.
15 Nassir A , Jollimore J , Gupta R , et al. Multilocular cystic renal cell carcinoma: A series of 12 cases and review of the literature[J]. Urology, 2002, 60 (3): 421- 427.
16 Gong K , Zhang N , He Z , et al. Multilocular cystic renal cell carcinoma: An experience of clinical management for 31 cases[J]. J Cancer Res Clin Oncol, 2008, 134 (4): 433- 437.
17 Pitra T , Pivovarcikova K , Alaghehbandan R , et al. A comprehensive commentary on the multilocular cystic renal neoplasm of low malignant potential: A urologist' s perspective[J]. Cancers (Basel), 2022, 14 (3): 831.
18 Cao C , Deng S , Wang B , et al. Intraoperative near-infrared Ⅱ window fluorescence imaging-assisted nephron-sparing surgery for complete resection of cystic renal masses[J]. Clin Transl Med, 2021, 11 (10): e604.
Outlines

/